Optiver Weighs In…

September 23rd, 2021 | For Subscribers

First HRT. Then Jump. Now, Optiver joins the chorus representing a collective "squeal" by a subset of secretive prop firms attempting to influence changes to US equity and options market structure...

Premium Research / Subscribers Only

This content is available to Alphacution subscribers only.

Sign in or create an account to access this content.

Explore Subscriptions

About Paul Rowady

Paul Rowady is the Director of Research for Alphacution, a research and strategic advisory platform uniquely focused on modeling and benchmarking the impacts of technology on global financial markets and the businesses of trading and asset management. He is a 35-year veteran of the proprietary, quantitative and derivatives trading arenas.

Contact: feedback@alphacution.com

Related Articles